Seeking Alpha The company's current commercial efforts are focused on five products: UCERIS™ (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis and ZEGERID® ( omeprazole /sodium ...
Business Standard We have done studies of this drug with pioglitazone, fenofibrate and atorvastatin and we have seen it is comparable to pioglitazone with its anti-diabetic effect without the usual side-effect of pioglitazone such as weight gain. Similarly, it does not ... and more »
7thSpace Interactive (press release) Although both compounds are more potent PPARalpha-activators than fenofibrate in vitro, only aleglitezar is more effective in lowering triglycerides and raising high-density lipoprotein-cholesterol (HDL-C) in humans. However, it is also associated with ...
7thSpace Interactive (press release) Although both compounds are more potent PPARalpha-activators than fenofibrate in vitro, only aleglitezar is more effective in lowering triglycerides and raising high-density lipoprotein-cholesterol (HDL-C) in humans. However, it is also associated with ...
Medisite Hypercholestérolémie et hypertriglycéridémie isolée ou combinée (dyslipidémies de type IIa, IIb, IV de même que les dyslipidémies de types III et V) des patients ne répondant pas à un régime adapté et d'autres mesures thérapeutiques non ...
7thSpace Interactive (press release) Although both compounds are more potent PPARalpha-activators than fenofibrate in vitro, only aleglitezar is more effective in lowering triglycerides and raising high-density lipoprotein-cholesterol (HDL-C) in humans. However, it is also associated with ...
7thSpace Interactive (press release) Although both compounds are more potent PPARalpha-activators than fenofibrate in vitro, only aleglitezar is more effective in lowering triglycerides and raising high-density lipoprotein-cholesterol (HDL-C) in humans. However, it is also associated with ...
